SANTA CLARA, Calif. & AMSTERDAM, Netherlands--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and Kreatech Biotechnology BV today announced the availability of labeling kits that, for the first time, enable oligo microarray comparative genomic hybridization (CGH) analysis of DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples.
